title: [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
abstract: 310 patients with pulmonary tuberculosis disseminating bacteria received isoniazid, rifampicin, streptomycin (ethambutol) and pirazinamid in different regimens and dosage forms. The drugs were administered in sequence or simultaneously, in single or divided doses. The best time and number characteristics as regards the discharge negativation were obtained in pirazinamid administration at a single dose daily or each other day irrespective of other drugs intake. 100 patients were given isoniazid, rifampicin and pirazinamid in multicomponent form tricox (Jemis, India). Tricox proved effective under additional administration of isoniazid in the same dose as was fixed in tricox.
authors.forename: G B
authors.initials: GB
authors.lastname: Sokolova
authors.forename: V A
authors.initials: VA
authors.lastname: Koriakin
authors.forename: I V
authors.initials: IV
authors.lastname: Khalbaeva
authors.forename: N A
authors.initials: NA
authors.lastname: Elistratova
authors.forename: A V
authors.initials: AV
authors.lastname: Ziia
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D004304:Dosage Forms; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents; D004304:Dosage Forms; D004338:Drug Combinations; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
vernacular_title: Kompleksnaia khimioterapiia bolńykh tuberkulëzom - novye rezhimy i lekarstvennye formy.